Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADH7 Inhibitors

ADH7 inhibitors belong to a distinct chemical class characterized by their ability to selectively target and modulate the activity of the alcohol dehydrogenase 7 (ADH7) enzyme. This enzyme plays a pivotal role in the metabolism of alcohols and other substrates in various biological systems. ADH7 inhibitors are designed to interact with the active site of the ADH7 enzyme, thereby hindering its catalytic function. This interaction effectively regulates the conversion of alcohols into corresponding aldehydes or ketones by impeding the enzyme's ability to facilitate the crucial oxidation-reduction reactions. The inhibitory action of these compounds on ADH7 is achieved through specific molecular interactions that disrupt the enzyme's three-dimensional structure and alter its active site conformation. This disruption prevents the binding of substrates and co-factors required for the enzymatic reaction. The design and development of ADH7 inhibitors involve a thorough understanding of the enzyme's structure and mechanism, enabling the creation of compounds with high selectivity and potency. These inhibitors serve as valuable tools in scientific research to unravel the physiological roles of ADH7 and its implications in various metabolic pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hh Signaling Antagonist VII, JK184

315703-52-7sc-202649
5 mg
$75.00
(1)

Hh Signaling Antagonist VII, JK184, acts as an ADH7 by disrupting specific protein-protein interactions within the Hedgehog signaling pathway. Its unique molecular architecture allows for selective inhibition, altering conformational dynamics of target proteins. The compound exhibits distinct kinetic profiles, with a notable impact on reaction rates under varying ionic strengths. Additionally, its amphiphilic nature enhances membrane permeability, influencing cellular uptake and localization.